×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Akari Therapeutics Secures $7.6 Million in Upsized Financing Round
Yahoo Finance Canada
BOSTON and LONDON, June 04, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing...
16 hours ago
Akari Therapeutics secures $7.6 million in private financing By Investing.com
Investing.com
BOSTON and LONDON - Akari Therapeutics Plc (NASDAQ:AKTX), a biotech firm focused on autoimmune and inflammatory diseases, has announced the...
10 hours ago
Akari Therapeutics raises $7.6M in upsized financing round (NASDAQ:AKTX)
Seeking Alpha
Akari Therapeutics raises $7.6M in private placement financing, garnering support from new and existing investors.
16 hours ago
Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com
Defense World
Read Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com at Defense World.
1 day ago
Akari Therapeutics enters merger deal with Peak Bio
Pharmaceutical Technology
Akari Therapeutics has signed an agreement with Peak Bio to merge in an all-stock transaction, creating a diversified pipeline.
2 months ago
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
GlobeNewswire
BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced...
1 month ago
Akari Therapeutics Announces Major Restructuring and Cost Cuts - TipRanks.com
Tipranks
Akari Therapeutics (AKTX) just unveiled an update. Akari Therapeutics, Plc is slashing its workforce by 67%, including some top management roles,...
1 month ago
AKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to ...
Business Wire
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Akari Therapeutics, Plc (NASDAQ: AKTX) and Peak Bio...
2 months ago
Insiders Who Purchased US$1.43m Of Akari Therapeutics Stock May Not Have Expected 21% Tumble
Simply Wall Street
Insiders who bought US$1.43m worth of Akari Therapeutics, Plc's ( NASDAQ:AKTX ) stock at an average buy price of...
2 months ago
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire
Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. Patel, M.D. Appointed...
3 weeks ago